Home › Funds › RIVERBRIDGE PARTNERS LLC › MEDP

RIVERBRIDGE PARTNERS LLC position in MEDP

MEDPACE HLDGS INC · Health Care

RIVERBRIDGE PARTNERS LLC reported holding 157,509 shares of MEDP (MEDPACE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$98.3M, representing 2.89% of its reported portfolio and ranking #5 among its reported holdings. RIVERBRIDGE PARTNERS LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)157.51K sh
Reported value held$98.31M
Portfolio Weight2.89%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How RIVERBRIDGE PARTNERS LLC's MEDP position evolved

RIVERBRIDGE PARTNERS LLC first disclosed a stake in MEDP in Q3 2023 at 640,907 shares (US$155.2M). The position peaked in Q1 2024 at 606,250 shares, worth US$245.0M. Across 13 filings, RIVERBRIDGE PARTNERS LLC increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 157,509 shares valued at US$98.3M — a reduction of -26,432 shares quarter over quarter.. Notable position changes include a 25% trim in Q4 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 640.91K $155.18M New
Q4 2023 683.94K $209.65M Add
Q1 2024 606.25K $245.02M Reduce
Q2 2024 536.00K $220.75M Reduce
Q3 2024 551.64K $184.14M Add
Q4 2024 517.53K $171.94M Reduce
Q1 2025 481.13K $146.59M Reduce
Q2 2025 434.02K $136.22M Reduce
Q3 2025 365.09K $187.71M Reduce
Q4 2025 272.97K $153.31M Reduce
Q1 2026 237.41K $114.00M Reduce
Q2 2026 183.94K $97.41M Reduce
Q3 2026 157.51K $98.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MEDP and 13F data

MEDP (MEDPACE HLDGS INC) is a Health Care company. 42 other funds we track also report a position in MEDP — the largest reported positions include WASATCH ADVISORS LP (US$290.8M), Renaissance Technologies (US$282.4M), Giverny Capital Inc. (US$152.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MEDP

All MEDP fund holders →

FAQ

How long has RIVERBRIDGE PARTNERS LLC held MEDP?

RIVERBRIDGE PARTNERS LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RIVERBRIDGE PARTNERS LLC's current position in MEDP?

As of Q3 2026, RIVERBRIDGE PARTNERS LLC holds 157.51K shares of MEDP (MEDPACE HLDGS INC), valued at $98.31M, representing 2.89% of its reported portfolio and ranking #5.

Has RIVERBRIDGE PARTNERS LLC been buying or selling MEDP?

In the latest 13F filing (Q3 2026), RIVERBRIDGE PARTNERS LLC reduced its position in MEDP. The position peaked in Q1 2024 at 606.25K shares.

Which other funds hold MEDP?

Other major institutional holders of MEDP include WASATCH ADVISORS LP, Renaissance Technologies, Giverny Capital Inc., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.